1 unchanged sentence
Securities Trading Plans of Directors and Executive Officers
−Removed: During our last fiscal quarter, none of our directors or officers, as defined in Rule 16a-1(f), adopted and/or terminated a “Rule 10b5-1 trading arrangement” or a “non-Rule 10b5-1 trading arrangement,” as defined in Regulation S-K Item 408.
+Added: During our last fiscal quarter ended June 30, 2026, Jim R.
+Added: Gibson , our Chief Financial Officer , adopted a Rule 10b5-1 trading arrangement on May 22, 2026 .
+Added: The trading arrangement is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended, has a planned duration from August 21, 2026 through March 15, 2027 , and provides for the potential sale of up to 661,685 shares of the Company's common stock.
+Added: Other than as disclosed above, none of our directors or officers, as defined in Rule 16a-1(f), adopted and/or terminated a “Rule 10b5-1 trading arrangement” or a “non-Rule 10b5-1 trading arrangement,” as defined in Regulation S-K Item 408.
Q2 Fiscal 2026 Form 10-Q
11 unchanged sentences
8-K 3.1 November 7, 2022
−Removed: Asset Purchase Agreement, dated January 30, 2026, by and between the Company, Illumina Cambridge Limited, and Illumina, Inc.
−Removed: 10.1 February 2, 2026
−Removed: Amended and Restated Outside Director Compensation Policy
−Removed: Filed herewith
+Added: Pacific Biosciences of California, Inc.
+Added: 2020 Equity Incentive Plan, as amended
+Added: 8-K 10.1 June 4, 2026
Certification of Chief Executive Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
16 unchanged sentences
______________________________________________________________________________
−Removed: † Certain portions of this exhibit have been omitted in accordance with Regulation S-K Item 601.
−Removed: The Company agrees to furnish an unredacted copy of the exhibit to the SEC upon request.
+ Indicates management contract or compensatory plan.
4 unchanged sentences
Pacific Biosciences of California, Inc.
−Removed: /s/ Christian O.
+Added: August 6, 2026
+Added: /s/ Mark Van Oene
+Added: Mark Van Oene
President and Chief Executive Officer
(Principal Executive Officer)
+Added: August 6, 2026
Chief Financial Officer
2 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.